Expanding Patient Access to Investigational New Drugs Overview of Intermediate and Widespread Treatment Investigational New Drugs, and Emergency Authorization in Public Health Emergencies

Overview of attention for article published in JACC: Basic to Translational Science, June 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

news: 3 news outlets
twitter: 2 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 28 Mendeley

Summary News X Facebook Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 105,037 followers.

RT @JACCJournals: What are the pros and cons of accelerating access to investigational drugs? Learn more in this Translational Toolbox: htt…

Reply Repost Favourite

What are the pros and cons of accelerating access to investigational drugs? Learn more in this Translational Toolbox: https://t.co/q92a46OPM6. #JACCBTS #openaccess #research https://t.co/x6XGheWLNY

Reply Repost Favourite